Insider Shareholders with Direct Ownership of Supernus Pharmaceuticals, Inc. (SUPN)
This section provides a comprehensive overview of the insiders with direct ownership of Supernus Pharmaceuticals, Inc. (SUPN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
SUPERNUS PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jack A. Khattar
President, CEO |
1,222,318 | 696,551 | 991,833 $32 Million | 64 |
Mar 10, 2025
Reduced 1.67%
|
|
Charles W Newhall Iii
Director |
53,538 | 13,200 | 135,644 $4.38 Million | 9 |
Feb 22, 2025
Added 3.81%
|
|
John M Siebert
Director |
26,990 | 0 | 87,943 $2.84 Million | 4 |
Feb 23, 2024
Added 4.23%
|
|
Tami Tillotson Martin
Sr. V.P., Regulatory Affairs |
36,600 | 38,216 | 86,933 $2.81 Million | 19 |
Feb 23, 2024
Reduced 0.55%
|
|
Frederick M. Hudson
Director |
53,538 | 17,815 | 53,764 $1.74 Million | 9 |
Feb 22, 2025
Added 9.08%
|
|
Gregory S Patrick
Sr. VP Chief Financial Officer |
25,000 | 25,000 | 44,463 $1.44 Million | 6 |
Nov 09, 2020
Reduced 10.11%
|
|
Carrolee Barlow
Director |
17,359 | 0 | 22,570 $728,559 | 4 |
Feb 22, 2025
Added 19.22%
|
|
Georges Gemayel
Director |
52,359 | 38,886 | 18,684 $603,119 | 10 |
Feb 22, 2025
Added 22.32%
|
|
Frank Mottola
SVP, Quality, GMP, Ops, IT |
36,250 | 30,060 | 15,151 $489,074 | 23 |
Mar 07, 2025
Reduced 8.21%
|
|
Padmanabh P. Bhatt
Sr. VP of IP, CSO |
164,650 | 155,359 | 12,704 $410,085 | 47 |
Mar 05, 2025
Reduced 4.33%
|
|
Timothy C Dec
Senior Vice-President & CFO |
20,300 | 9,933 | 12,681 $409,342 | 15 |
Mar 10, 2025
Reduced 7.0%
|
|
Jonathan Rubin
SVP, Chief Medical Officer |
12,600 | 4,571 | 9,635 $311,017 | 15 |
Mar 05, 2025
Reduced 5.65%
|
|
Bethany Sensenig
Director |
5,369 | 0 | 5,369 $173,311 | 1 |
Feb 22, 2025
Added 50.0%
|
|
Stefan K.F. Schwabe
Executive Vice President & CMO |
100,000 | 100,000 | 2,772 $89,480 | 4 |
Dec 21, 2020
Reduced 94.36%
|